Craig S. Sauter
Hematology
9500 Euclid Avenue
Cleveland, OH 44195
Cleveland, OH 44195
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications
Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma Treated With CAR T-Cell Therapies.
Journal: Transplantation and cellular therapy
Published: April 17, 2026
Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: February 02, 2026
Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: February 02, 2026
American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 09, 2025
CD19 CAR T-Cell Therapy in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Journal: American journal of hematology
Published: November 05, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis.
Journal: Transplantation and cellular therapy
Published: October 11, 2025
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.
Journal: Cancer
Published: September 24, 2025
Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic Malignancies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 17, 2025
Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy.
Journal: Transplantation and cellular therapy
Published: July 15, 2025
Corrigendum to 'Clinical Practice Recommendations for Hematopoietic Cell Transplantation.' Transplant Cell Ther. 2024 Sep;30(9):832-843.
Journal: Transplantation and cellular therapy
Published: June 24, 2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Journal: Bone marrow transplantation
Published: April 16, 2025
Last Updated: 09/26/2026